Univ. Doz. Dr. Willibald Gerschlager Krankenhaus der Barmherzigen Brüder Neurologische Abteilung 1020 Wien PUBLIKATIONSLISTE ERSTAUTORSCHAFTEN
1) Gerschlager W. Kurzfassung der Dissertation: In-vivo Studie über den Einfluß von
Neurotransmittern auf den Gefäßtonus. Wien Klin Wochenschr 1994;106:531-533.
(Impact Factor: 0.3).
2) Gerschlager W, Lalouschek W, Lehrner J, Baumgartner C, Lindinger G, Lang W.
Language - related hemispheric asymmetry in healthy subjects and patients with
temporal lobe epilepsy as studied by event-related potentials and intracarotid amobarbital
test. Electroenceph clin Neurophysiol 1998;108:274-282. (Impact Factor: 2. 5).
3) Gerschlager W, Alesch F, Cunnington R, Deecke L, Dirnberger G, Endl W, Lindinger G,
Lang W. Bilateral subthalamic nucleus stimulation improves frontal cortex function in
Parkinson’s disease: An electrophysiological study of the contingent negative variation.
Brain 1999;122:2365-2373. (Impact Factor: 7. 4).
4) Gerschlager W, Beisteiner R, Deecke L, Dirnberger G, Endl W, Kollegger H, Lindinger
G, Vass K, Lang W. Electrophysiological, neuropsychological and clinical findings in
multiple sclerosis patients receiving Interferon -1b. A 1-year follow-up. European
Neurology 2000;44:205-209. (Impact Factor: 1.1).
5) Gerschlager W, Bloem BR, Alesch F, Lang W, Deecke L, Cunnington R. Bilateral
subthalamic nucleus stimulation does not improve prolonged P300 latencies in
Parkinson’s disease. J Neurology 2001;248:285-289. (Impact Factor 2.7).
6) Gerschlager W, Siebner HR, Rothwell JC. Decreased corticospinal excitability after
subthreshold 1 Hz rTMS over lateral premotor cortex. Neurology 2001;57:449-455.
(Impact Factor: 4. 8).
7) Gerschlager W, Bencsits G, Pirker W, Bloem BR, Asenbaum S, Prayer D, Zijlmans
JCM, Hoffmann M, Brücke T. [123I]-CIT SPECT distinguishes vascular parkinsonism
from Parkinson’s disease. Mov Disord 2002;17:518-523. (Impact Factor: 2.5).
8) Gerschlager W, Brown P. Effect of treatment with intravenous immunoglobulin on
quality of life in patients with stiff-person syndrome. Mov Disord 2002;17:590-593.
(Impact Factor: 2.5).
9) Gerschlager W, Schrag A, Brown P. Quality of life in the stiff-person syndrome. Mov
Disord 2002; 17:1064-1067. (Impact Factor: 2.5).
10) Gerschlager W, Christensen LOD, Bestmann S, Rothwell JC. rTMS over the cerebellum
can increase corticospinal excitability through a spinal mechanism involving activation
of peripheral nerve fibres. Clin Neurophysiol 2002;113:1435-1440. (Impact Factor: 3.3).
11) Gerschlager W, Katzenschlager R, Schrag A, Lees AJ, Brown P, Quinn N, Bhatia K.
Quality of life in patients with orthostatic tremor. J Neurol 2003;2:212-215. (Impact
Factor 3.3).
12) Gerschlager W, Münchau A, Katzenschlager R, Brown P, Rothwell JC, Quinn N, Lees
AJ, Bhatia K. Natural history and syndromic associations of orthostatic tremor: a review
of 41 patients. Mov Disord 2004;19:788-795. (Impact Factor 2.8).
13) Gerschlager W, Holler I Cunnington R, Siebner HR. 5Hz rTMS over the motor cortex
improves motor symptoms in patients with Parkinson’s disease. submittedARBEITEN ALS „SENIOR-AUTOR“
14) Bloem BR, Boers I, Cramer M, Westendorp RGJ, Gerschlager W. Falls in the elderly. I.
Identifikation of risk factors. Wien Klin Wochenschr 2001;113:352-62. (Impact Factor:
15) Holler I, Dirnberger G, Pirker W, Auff E, Gerschlager W. [123I]-CIT SPECT and
clinical characteristics in two Parkinson’s disease patients associated with
camptocormia. European Neurology 2003;50:118-20. (Impact Factor: 1.1).
16) Holler I, Siebner HR, Cunnington R, Gerschlager W. 5Hz repetitive TMS increases
anticipatory motor activity in the human cortex. Neuroscience Letters 2006;392: 221-
225. (Impact Factor: 2.1). KOAUTORSCHAFTEN
17) Wolzt M, Gerschlager W, Zweytick B, Sertl K, Eichler HG. Effects of NPY and VIP on
human venous smooth muscle in vivo. Naunyn Schmiedebergs Arch Pharmacol
1994;350:194-200. (Impact Factor: 2.8).
18) Schnider P, Reisinger EC, Gerschlager W, Müller C, Berger T, Krejs GJ, Auff E. Long -
term follow - up in cerebral Whipple’s disease. Eur J Gastroenterol Hepatol 1996;8:899-
903. (Impact Factor: 0.8).
19) Lang W, Cheyne D, Höllinger P, Gerschlager W, Lindinger G. Electric and magnetic
fields of the brain accompanying internal stimulation of movements. Cognitive Brain
Res 1996;3:125-29. (Impact Factor: 2.2).
20) Lalouschek W, Gerschlager W, Lehrner J, Baumgartner C, Lindinger G, Lang W. Event-
related potentials in patients with temporal lobe epilepsy reveal topography specific
lateralization in relation to the side of the epileptic focus. Electroenceph clin
Neurophysiol 1998;108:567-76. (Impact Factor: 2.4).
21) Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, Brücke T.
[123I]-CIT-SPECT in multiple system atrophy, progressive supranuclear palsy and
corticobasal degeneration. Mov Disord 2000;15:1158-67. (Impact Factor 2.5).
22) Touge T, Gerschlager W, Brown P, Rothwell JC. Are the after-effects of low frequency
rTMS on motor cortex excitability due to changes in the efficacy of cortical synapses?
Clin Neurophysiol 2001;112:2138-45. (Impact Factor: 3.3).
23) Boers I, Gerschlager W, Stalenhoef PA, Bloem BR. Falls in the elderly. II. Strategies for
prevention. Wien Klin Wochenschr 2001;113:398-407. (Impact Factor: 0.6).
24) Pirker W, Djamshidian S, Asenbaum S, Gerschlager W, Tribl G, Hoffmann M, Brücke
T. The progression of dopaminergic degeneration in Parkinson's disease and atypical
parkinsonism: A longitudinal beta-CIT SPECT study. Mov Disord 2002;17:45-53.
(Impact Factor: 2.5).
25) Strens LH, Oliviero A, Bloem BR, Gerschlager W, Rothwell JC, Brown P. The effects of
subthreshold 1 Hz repetitive TMS on cortico-cortical and interhemispheric coherence.
Clin Neurophysiol 2002;113:1279-85. (Impact Factor: 3.3).
26) Katzenschlager R, Costa D, Gerschlager W, O’Sullivan J, Zijlmans J, Gacinovic S,
Pirker W, Wills A, Bhatia K, Lees AJ, Brown P. [123I]-FP-CIT-SPECT demonstrates
dopaminergic deficit in orthostatic tremor. Ann Neurol 2003;53:489-96. (Impact Factor:
27) Siebner HR, Filipovic SR, Rowe JB, Cordivari C, Gerschlager W, Rothwell JC,
Frackowiack RS, Bhatia KP. Patients with focal arm dystonia have increased sensitivity
to slow-frequency repetitive TMS over the dorsal premotor cortex. Brain
2003;126:2710-25. (Impact Factor: 7.3).
28) Pirker W, Back C, Gerschlager W, Laccone F, Alesch F. Chronic thalamic stimulation in
a patient with spinocerebellar ataxia type 2. Mov Disord 2003;2:221-225. (Impact
Factor: 2.5).
29) Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettnig G, Brucke T. Measuring the
rate of progression of Parkinson’s disease over a 5-year period with beta-CIT SPECT.
Mov Disord 2003;18:1266-72. (Impact Factor: 2.5).
30) Rizzo V, Siebner HR, Modugno N, Pesenti A, Munchau A, Gerschlager W, Webb RM,
Rothwell JC. Shaping the excitability of human motor cortex with premotor rTMS. J
Physiol 2004;15:483-485. (Impact Factor: 4.3).
31) Filipovic SR, Siebner HR, Rowe JB, Cordivari C, Gerschlager W, Rothwell JC,
Frackowiack RS, Bhatia KP. Modulation of corticalo activity by repetitive transcranial
magnetic stimulation (rTMS): a review of functional imaging studies and the potential
use in dystonia. Adv Neurol 2004;94:45-52. (Impact Factor: 1.4).
32) Münchau A, Langosch JM, Gerschlager W, Rothwell J, Orth M, Trimble MR.
Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with
major depression. J Neurol Neurosurg Psychiatry 2005;76:527-533. (Impact Factor: 2.8).
33) Sauermann S, Standhardt H, Gerschlager W, Lanmüller H, Alesch F. Kinematic
evaluation in Parkinson’s disease using a hand-held position transducer and computeized
signal analysis. Acta Neurochir (Wien) 2005;147:939-945. (Impact Factor: 1).
34) Rowe JB, Siebner H, Filipovic SR, Cordivari C, Gerschlager W, Rothwell JC,
Frackowiak R. Aging is associated with contrasting chances in local and distant cortical
connectivity in the human motor system. Neuroimage 2006;32: 747-760. (Impact Factor:
It’s easy, it works and it’s free for all members of Blue Cross and Blue Shield of Minnesota. Call and quit in your own way, at your own pace. Speak with a Quit Coach — a professional with special training in quitting smoking. They don’t nag or judge. In fact, many of them are former smokers themselves. They offer encouragement and a plan for Quit in your way, at your own p